期刊文献+

美罗华治疗B细胞性非霍奇金淋巴瘤的护理

The Observation and Nursing of Mab Thera's ill Reaction
下载PDF
导出
摘要 目的:探讨美罗华(MabThera)治疗B细胞性非霍奇金淋巴瘤的观察及护理。方法:通过应用美罗华16次,观察用药过程中的不良反应,采取护理对策。结果:1例第一次输注时出现发热、寒战。结论:美罗华应用时不良反应轻微,但要掌握正确的给药方法,严格按医嘱调整滴速,行心电监护,严密监测生命体征,及时发现不良反应及时处理,将药物的不良反应降至最低。 Objective: Discussing the observation and nursing of the ill reaction during the therapy of Bcell non - Hodgkin lymphoma with Mab Thera. Methods:By using Mab Thera 16 times,observing the ill reaction during the medication and nursing countermeasure. Results: Only one case occurred fever ,chill in the first time transfusion. Conclusions: The ill -reaction during the using of Mab Thera is mild ,but the correct transfusion technique should be grasped ,adjusting the transfusion rate according to doctor's advice , monitoring life sign strictly with electrocardiographic, detecting ill- reactions in time and treating it betimes, Reducing the remedy ill reaction at full steam.
机构地区 河南省肿瘤医院
出处 《中国民康医学》 2007年第13期595-596,共2页 Medical Journal of Chinese People’s Health
关键词 美罗华 不良反应 护理 MabThera Ill - Reaction Nursing
  • 相关文献

参考文献2

二级参考文献4

  • 1Vose JM, Link BK, Grossbard ML, et al. Phase Ⅱ study of Rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive Non-Hodgkin's lymphoma[J]. J Clin Oncol,2001,15(2):389-397.
  • 2Coiffier B, Haioun C, Ketterer N, et al. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase Ⅱ study[J].Blood,1998,92(6):1927-1932.
  • 3Lopez M, Perno CF, Di Lauro, et al . Epirubicin in non-Hodgkin's lymphoma[J]. Am J Clin Oncol, 1985, 8(2):151-153.
  • 4Coiffier B, Lepage E, Briere J,et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma[J]. N Eng J Med,2002,346(4):235-242.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部